This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
British Journal of Cancer Open Access 22 October 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C et al. The third intergroup rhabdomyosarcoma study. J Clin Oncol 1995; 13: 610–630.
Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM et al. Prognostic factors and clinical outcome in children and adolescents with metastatic rhabdomyosarcoma—a report from the intergroup rhabdomyosarcoma study IV. J Clin Oncol 2003; 21: 78–84.
Carli M, Colombatti R, Oberlin O, Bisogno B, Treuner J, Koscielniak E et al. European intergroup studies (MMT 4-89 and NMT 4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol 2004; 22: 4787–4794.
Klingebiel T, Boos J, Beske F, Hallmen E, Int-Veen C, Dantonello T et al. Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer 2008; 50: 739–745.
Weigel BJ, Breitfeld PP, Hawkins D, Crist WM, Baker KS . Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma. J Pediatr Hematol Oncol 2001; 5: 272–276.
Childs R, Srinivasan R . Advances in allogeneic stem cell transplantation: directing graft-versus-leukemia at solid tumors. Cancer J 2002; 8: 2–11.
Doelken R, Weigel S, Schueler F, Doelken G, Beck JF . Poor outcome of two children with relapsed state stage IV rhabdomyosarcoma after allogeneic stem cell transplantation. Pediatr Hematol Oncol 2005; 22: 699–703.
Bader P, Hancock J, Kreyenberg H, Goulden NJ, Niethammer D, Oakhill A et al. Minimal residual disease status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with all. Leukemia 2002; 16: 1668–1672.
Misawa A, Hosoi H, Tsuchiya K, Iehara T, Sawada T, Sugimoto T . Regression of refractory rhabdomyosarcoma after allogeneic stem cell transplantation. Pediatr Hematol Oncol 2003; 20: 151–155.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Donker, A., Hoogerbrugge, P., Mavinkurve-Groothuis, A. et al. Metastatic rhabdomyosarcoma cured after chemotherapy and allogeneic SCT. Bone Marrow Transplant 43, 179–180 (2009). https://doi.org/10.1038/bmt.2008.301
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.301
This article is cited by
-
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
British Journal of Cancer (2013)
-
Childhood Rhabdomyosarcoma: New Insight on Biology and Treatment
Current Oncology Reports (2010)
-
Allogeneic and autologous stem cell transplantation in advanced small round cell sarcomas
Journal of Orthopaedic Science (2010)